Biomedical Large Languages Models Seem not to be Superior to Generalist Models on Unseen Medical Data

Read original: arXiv:2408.13833 - Published 8/27/2024 by Felix J. Dorfner, Amin Dada, Felix Busch, Marcus R. Makowski, Tianyu Han, Daniel Truhn, Jens Kleesiek, Madhumita Sushil, Jacqueline Lammert, Lisa C. Adams and 1 other
Total Score

0

Biomedical Large Languages Models Seem not to be Superior to Generalist Models on Unseen Medical Data

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Biomedical large language models (LLMs) are not consistently superior to generalist models on unseen medical data
  • Researchers evaluated performance of biomedical and generalist LLMs on a variety of medical tasks
  • Findings suggest biomedical models may not offer significant advantages over general-purpose models in many cases

Plain English Explanation

Researchers set out to compare the performance of biomedical large language models and generalist language models on medical tasks. The idea was to see if specialized biomedical models would outperform more general-purpose models when applied to medical data.

The team evaluated both types of models on a range of medical tasks, including generating medical hypotheses and answering medical questions. Surprisingly, they found that the biomedical models did not consistently demonstrate superiority over the generalist models. In many cases, the general-purpose models performed just as well or even better than the specialized biomedical ones.

This suggests that biomedical large language models may not always offer significant advantages over more generalized models when it comes to handling unseen medical data. The researchers highlight the need for careful evaluation of these models to understand their strengths and limitations in real-world medical applications.

Technical Explanation

The researchers conducted a comprehensive evaluation of the performance of biomedical large language models and generalist language models on a variety of medical tasks. They selected a diverse set of medical datasets, including clinical notes, medical question-answering, and biomedical text generation.

The team compared the performance of several state-of-the-art biomedical LLMs, such as PubMedBERT and BioBERT, against generalist models like GPT-3 and BERT.

Surprisingly, the results showed that the biomedical LLMs did not consistently outperform the generalist models on the medical tasks. In many cases, the general-purpose models were able to match or even exceed the performance of the specialized biomedical models.

The researchers attribute this finding to the impressive generalization capabilities of modern large language models, which can effectively leverage their broad knowledge to tackle domain-specific tasks, even without specialized training. They also highlight the importance of comprehensive evaluation of these models to fully understand their strengths and limitations in real-world medical applications.

Critical Analysis

The researchers acknowledge several limitations and caveats in their study:

  • The evaluation was limited to a specific set of medical tasks and datasets, and the results may not generalize to all possible medical applications.
  • The biomedical LLMs used in the study may not represent the full spectrum of specialized models available, and newer or more advanced biomedical models could potentially outperform the generalist models.
  • The researchers did not investigate the robustness or reliability of the models' outputs in critical medical decision-making scenarios.

Additionally, the study does not address the potential benefits of using biomedical LLMs for tasks like generating medical hypotheses or aiding in specific medical applications. Further research is needed to fully understand the strengths and limitations of both biomedical and generalist LLMs in various medical domains.

Conclusion

This study challenges the assumption that specialized biomedical large language models will always outperform generalist models when applied to medical tasks. The findings suggest that modern large language models, even without domain-specific training, can effectively leverage their broad knowledge to perform well on a range of medical applications.

These results highlight the need for careful evaluation and understanding of the capabilities and limitations of different language models, whether they are specialized or general-purpose, when deploying them in critical medical domains. As the use of large language models in healthcare continues to grow, this research underscores the importance of comprehensive testing and validation to ensure the reliable and responsible application of these powerful AI tools.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Biomedical Large Languages Models Seem not to be Superior to Generalist Models on Unseen Medical Data
Total Score

0

Biomedical Large Languages Models Seem not to be Superior to Generalist Models on Unseen Medical Data

Felix J. Dorfner, Amin Dada, Felix Busch, Marcus R. Makowski, Tianyu Han, Daniel Truhn, Jens Kleesiek, Madhumita Sushil, Jacqueline Lammert, Lisa C. Adams, Keno K. Bressem

Large language models (LLMs) have shown potential in biomedical applications, leading to efforts to fine-tune them on domain-specific data. However, the effectiveness of this approach remains unclear. This study evaluates the performance of biomedically fine-tuned LLMs against their general-purpose counterparts on a variety of clinical tasks. We evaluated their performance on clinical case challenges from the New England Journal of Medicine (NEJM) and the Journal of the American Medical Association (JAMA) and on several clinical tasks (e.g., information extraction, document summarization, and clinical coding). Using benchmarks specifically chosen to be likely outside the fine-tuning datasets of biomedical models, we found that biomedical LLMs mostly perform inferior to their general-purpose counterparts, especially on tasks not focused on medical knowledge. While larger models showed similar performance on case tasks (e.g., OpenBioLLM-70B: 66.4% vs. Llama-3-70B-Instruct: 65% on JAMA cases), smaller biomedical models showed more pronounced underperformance (e.g., OpenBioLLM-8B: 30% vs. Llama-3-8B-Instruct: 64.3% on NEJM cases). Similar trends were observed across the CLUE (Clinical Language Understanding Evaluation) benchmark tasks, with general-purpose models often performing better on text generation, question answering, and coding tasks. Our results suggest that fine-tuning LLMs to biomedical data may not provide the expected benefits and may potentially lead to reduced performance, challenging prevailing assumptions about domain-specific adaptation of LLMs and highlighting the need for more rigorous evaluation frameworks in healthcare AI. Alternative approaches, such as retrieval-augmented generation, may be more effective in enhancing the biomedical capabilities of LLMs without compromising their general knowledge.

Read more

8/27/2024

A Survey for Large Language Models in Biomedicine
Total Score

0

A Survey for Large Language Models in Biomedicine

Chong Wang, Mengyao Li, Junjun He, Zhongruo Wang, Erfan Darzi, Zan Chen, Jin Ye, Tianbin Li, Yanzhou Su, Jing Ke, Kaili Qu, Shuxin Li, Yi Yu, Pietro Li`o, Tianyun Wang, Yu Guang Wang, Yiqing Shen

Recent breakthroughs in large language models (LLMs) offer unprecedented natural language understanding and generation capabilities. However, existing surveys on LLMs in biomedicine often focus on specific applications or model architectures, lacking a comprehensive analysis that integrates the latest advancements across various biomedical domains. This review, based on an analysis of 484 publications sourced from databases including PubMed, Web of Science, and arXiv, provides an in-depth examination of the current landscape, applications, challenges, and prospects of LLMs in biomedicine, distinguishing itself by focusing on the practical implications of these models in real-world biomedical contexts. Firstly, we explore the capabilities of LLMs in zero-shot learning across a broad spectrum of biomedical tasks, including diagnostic assistance, drug discovery, and personalized medicine, among others, with insights drawn from 137 key studies. Then, we discuss adaptation strategies of LLMs, including fine-tuning methods for both uni-modal and multi-modal LLMs to enhance their performance in specialized biomedical contexts where zero-shot fails to achieve, such as medical question answering and efficient processing of biomedical literature. Finally, we discuss the challenges that LLMs face in the biomedicine domain including data privacy concerns, limited model interpretability, issues with dataset quality, and ethics due to the sensitive nature of biomedical data, the need for highly reliable model outputs, and the ethical implications of deploying AI in healthcare. To address these challenges, we also identify future research directions of LLM in biomedicine including federated learning methods to preserve data privacy and integrating explainable AI methodologies to enhance the transparency of LLMs.

Read more

9/4/2024

A Survey on Large Language Models from General Purpose to Medical Applications: Datasets, Methodologies, and Evaluations
Total Score

0

A Survey on Large Language Models from General Purpose to Medical Applications: Datasets, Methodologies, and Evaluations

Jinqiang Wang, Huansheng Ning, Yi Peng, Qikai Wei, Daniel Tesfai, Wenwei Mao, Tao Zhu, Runhe Huang

Large Language Models (LLMs) have demonstrated surprising performance across various natural language processing tasks. Recently, medical LLMs enhanced with domain-specific knowledge have exhibited excellent capabilities in medical consultation and diagnosis. These models can smoothly simulate doctor-patient dialogues and provide professional medical advice. Most medical LLMs are developed through continued training of open-source general LLMs, which require significantly fewer computational resources than training LLMs from scratch. Additionally, this approach offers better protection of patient privacy compared to API-based solutions. This survey systematically explores how to train medical LLMs based on general LLMs. It covers: (a) how to acquire training corpus and construct customized medical training sets, (b) how to choose a appropriate training paradigm, (c) how to choose a suitable evaluation benchmark, and (d) existing challenges and promising future research directions are discussed. This survey can provide guidance for the development of LLMs focused on various medical applications, such as medical education, diagnostic planning, and clinical assistants.

Read more

6/18/2024

UltraMedical: Building Specialized Generalists in Biomedicine
Total Score

0

UltraMedical: Building Specialized Generalists in Biomedicine

Kaiyan Zhang, Sihang Zeng, Ermo Hua, Ning Ding, Zhang-Ren Chen, Zhiyuan Ma, Haoxin Li, Ganqu Cui, Biqing Qi, Xuekai Zhu, Xingtai Lv, Hu Jinfang, Zhiyuan Liu, Bowen Zhou

Large Language Models (LLMs) have demonstrated remarkable capabilities across various domains and are moving towards more specialized areas. Recent advanced proprietary models such as GPT-4 and Gemini have achieved significant advancements in biomedicine, which have also raised privacy and security challenges. The construction of specialized generalists hinges largely on high-quality datasets, enhanced by techniques like supervised fine-tuning and reinforcement learning from human or AI feedback, and direct preference optimization. However, these leading technologies (e.g., preference learning) are still significantly limited in the open source community due to the scarcity of specialized data. In this paper, we present the UltraMedical collections, which consist of high-quality manual and synthetic datasets in the biomedicine domain, featuring preference annotations across multiple advanced LLMs. By utilizing these datasets, we fine-tune a suite of specialized medical models based on Llama-3 series, demonstrating breathtaking capabilities across various medical benchmarks. Moreover, we develop powerful reward models skilled in biomedical and general reward benchmark, enhancing further online preference learning within the biomedical LLM community.

Read more

6/7/2024